AB661
☆    

India,
2020-08-19 11:22
(1723 d 22:57 ago)

Posting: # 21888
Views: 2,147
 

 Metformin Bioequivalence Study [Design Issues]

Dear Colleagues,

I need your advice please for Metformin Oral Solution. As per Orange book it have AB TE code.
Should BE required to support ANDA application?

Metformin has non-linear pharmacokinetics. There No OGD BE guidance for this product . Whether BE study should be conducted with 500 dose or 1000 mg dose.

I would be grateful if someone could guide me.

With regards
AB
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
96 visitors (0 registered, 96 guests [including 11 identified bots]).
Forum time: 10:20 CEST (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5